2024-09-24 - Analysis Report
## Cigna Group (CI) Stock Analysis

### Company Overview
Cigna Group is a global health service company offering health, dental, pharmacy, behavioral health, and disability insurance.

### Performance Comparison
* **Cumulative Return:** Cigna has outperformed the S&P 500 (VOO) by 27.33% since the start of the evaluation period. This translates to a relative outperformance of 51.8% based on historical data.
* **Recent Price Movements:**
    * **Closing Price:** $354.94
    * **5-day Moving Average:** $355.74
    * **20-day Moving Average:** $358.77
    * **60-day Moving Average:** $343.66
    * **Interpretation:** The stock is trading slightly below its 5-day and 20-day moving averages, indicating potential downward pressure in the short term. However, the 60-day moving average suggests a longer-term bullish trend.

### Technical Indicators
* **RSI:** 37.59 - This suggests that the stock is currently in oversold territory, indicating potential for a rebound.
* **PPO:** -0.4 - A negative PPO value indicates that the stock price is declining relative to its 12-day moving average.
* **Delta_Previous_Relative_Divergence:** -2.26 - This suggests a recent decline in the stock's relative outperformance, which may indicate short-term weakness.
* **Expected Return:** 46.51% - This indicates a potential 5-year return based on current investment, assuming continued market growth.

### Recent Earnings and Outlook
| Date | EPS | Revenue |
|---|---|---|
| 2024-08-01 | 5.51 | 60.52 B$ |
| 2024-05-02 | -0.97 | 57.26 B$ |
| 2023-11-02 | 4.79 | 49.05 B$ |
| 2023-08-03 | 4.96 | 48.59 B$ |
| 2024-08-01 | 4.96 | 48.59 B$ |

Cigna's recent earnings have been mixed, with the most recent quarter showing a significant increase in EPS and revenue. While the company's long-term prospects remain positive, investors should keep a close eye on the impact of economic factors on its health insurance business.

### Overall Analysis
Cigna Group has consistently outperformed the S&P 500 in the past and currently shows potential for a rebound based on its oversold technical indicators and recent strong earnings. However, investors should acknowledge the potential for short-term weakness given the recent decline in relative outperformance and the stock's trading below its moving averages. Long-term prospects remain positive, driven by the company's dominant position in the health insurance market and potential for continued revenue growth. Despite the recent negative divergence, Cigna's strong performance and potential for future growth make it a compelling investment opportunity. However, monitoring market trends and potential risks associated with the health insurance industry remains crucial for investors. 
